{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:28:36Z","timestamp":1781641716555,"version":"3.54.5"},"reference-count":39,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.bbrc.2015.09.179","type":"journal-article","created":{"date-parts":[[2015,11,3]],"date-time":"2015-11-03T05:54:12Z","timestamp":1446530052000},"page":"394-399","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Exendin-4 attenuates cardiac hypertrophy via AMPK\/mTOR signaling pathway activation"],"prefix":"10.1016","volume":"468","author":[{"given":"Yue","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yili","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangui","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2015.09.179_bib1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.diabres.2009.10.007","article-title":"Global estimates of the prevalence of diabetes for 2010 and 2030","volume":"87","author":"Shaw","year":"2010","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.bbrc.2015.09.179_bib2","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1161\/CIRCULATIONAHA.106.679597","article-title":"Diabetic cardiomyopathy revisited","volume":"115","author":"Boudina","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2015.09.179_bib3","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.pharmthera.2014.01.003","article-title":"Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways","volume":"142","author":"Huynh","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbrc.2015.09.179_bib4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.physiol.65.092101.142243","article-title":"Cardiac hypertrophy: the good, the bad, and the ugly","volume":"65","author":"Frey","year":"2003","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.bbrc.2015.09.179_bib5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S1937-6448(10)84003-1","article-title":"What causes a broken heart-molecular insights into heart failure","volume":"284","author":"Barry","year":"2010","journal-title":"Int. Rev. Cell Mol. Biol."},{"key":"10.1016\/j.bbrc.2015.09.179_bib6","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.phrs.2009.11.012","article-title":"Molecular targets and regulators of cardiac hypertrophy","volume":"61","author":"Rohini","year":"2010","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbrc.2015.09.179_bib7","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/nature06798","article-title":"Tackling heart failure in the twenty-first century","volume":"451","author":"Mudd","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2015.09.179_bib8","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","article-title":"The physiology of glucagon-like peptide 1","volume":"87","author":"Holst","year":"2007","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbrc.2015.09.179_bib9","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0014-5793(94)01430-9","article-title":"Tissue-specific expression of the human receptor for glucagon-like peptide-I: brain, heart and pancreatic forms have the same deduced amino acid sequences","volume":"358","author":"Wei","year":"1995","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbrc.2015.09.179_bib10","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1093\/eurheartj\/ehr309","article-title":"Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction","volume":"33","author":"Lonborg","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbrc.2015.09.179_bib11","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s00395-015-0476-7","article-title":"Exendin-4 protects against post-myocardial infarction remodelling via specific actions on inflammation and the extracellular matrix","volume":"110","author":"Robinson","year":"2015","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.bbrc.2015.09.179_bib12","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2337\/diabetes.54.1.146","article-title":"Glucagon-like peptide 1 can directly protect the heart against ischemia\/reperfusion injury","volume":"54","author":"Bose","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.bbrc.2015.09.179_bib13","doi-asserted-by":"crossref","first-page":"975","DOI":"10.2337\/db08-1193","article-title":"GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice","volume":"58","author":"Noyan-Ashraf","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.bbrc.2015.09.179_bib14","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1161\/01.CIR.0000139339.85840.DD","article-title":"Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy","volume":"110","author":"Nikolaidis","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2015.09.179_bib15","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1161\/CIRCHEARTFAILURE.108.766402","article-title":"Chronic glucagon-like peptide-1 infusion sustains left ventricular systolic function and prolongs survival in the spontaneously hypertensive, heart failure-prone rat","volume":"1","author":"Poornima","year":"2008","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.bbrc.2015.09.179_bib16","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1475-2840-9-76","article-title":"Glucagon-like peptide-1 and the exenatide analogue AC3174 improve cardiac function, cardiac remodeling, and survival in rats with chronic heart failure","volume":"9","author":"Liu","year":"2010","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.bbrc.2015.09.179_bib17","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1042\/CS20080066","article-title":"AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease","volume":"116","author":"Wong","year":"2009","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.bbrc.2015.09.179_bib18","doi-asserted-by":"crossref","first-page":"24194","DOI":"10.1074\/jbc.M802869200","article-title":"Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt","volume":"283","author":"Chan","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2015.09.179_bib19","doi-asserted-by":"crossref","first-page":"32771","DOI":"10.1074\/jbc.M403528200","article-title":"Activation of AMP-activated protein kinase inhibits protein synthesis associated with hypertrophy in the cardiac myocyte","volume":"279","author":"Chan","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2015.09.179_bib20","doi-asserted-by":"crossref","first-page":"18465","DOI":"10.1074\/jbc.M110.200022","article-title":"Resistin promotes cardiac hypertrophy via the AMP-activated protein kinase\/mammalian target of rapamycin (AMPK\/mTOR) and c-Jun N-terminal kinase\/insulin receptor substrate 1 (JNK\/IRS1) pathways","volume":"286","author":"Kang","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2015.09.179_bib21","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.diabres.2012.04.001","article-title":"Exendin-4 directly improves endothelial dysfunction in isolated aortas from obese rats through the cAMP or AMPK-eNOS pathways","volume":"97","author":"Han","year":"2012","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.bbrc.2015.09.179_bib22","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1161\/CIRCULATIONAHA.112.091215","article-title":"A\u00a0glucagon-like peptide-1 analog reverses the molecular pathology and cardiac dysfunction of a mouse model of obesity","volume":"127","author":"Noyan-Ashraf","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.bbrc.2015.09.179_bib23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.peptides.2012.10.006","article-title":"The human glucagon-like peptide-1 analogue liraglutide regulates pancreatic beta-cell proliferation and apoptosis via an AMPK\/mTOR\/P70S6K signaling pathway","volume":"39","author":"Miao","year":"2013","journal-title":"Peptides"},{"key":"10.1016\/j.bbrc.2015.09.179_bib24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.bbrc.2014.10.079","article-title":"REDD1 attenuates cardiac hypertrophy via enhancing autophagy","volume":"454","author":"Liu","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2015.09.179_bib25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.biocel.2014.11.018","article-title":"Hyperglycemia-induced GLP-1R downregulation causes RPE cell apoptosis","volume":"59","author":"Kim","year":"2015","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bbrc.2015.09.179_bib26","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1210\/en.2003-0007","article-title":"Cardiac function in mice lacking the glucagon-like peptide-1 receptor","volume":"144","author":"Gros","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbrc.2015.09.179_bib27","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.2337\/db06-1033","article-title":"Downregulation of GLP-1 and GIP receptor expression by hyperglycemia: possible contribution to impaired incretin effects in diabetes","volume":"56","author":"Xu","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.bbrc.2015.09.179_bib28","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/j.1478-3231.2011.02462.x","article-title":"Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis","volume":"31","author":"Svegliati-Baroni","year":"2011","journal-title":"Liver Int."},{"key":"10.1016\/j.bbrc.2015.09.179_bib29","doi-asserted-by":"crossref","first-page":"684","DOI":"10.3892\/ijmm.2014.2052","article-title":"Liraglutide inhibits autophagy and apoptosis induced by high glucose through GLP-1R in renal tubular epithelial cells","volume":"35","author":"Zhao","year":"2015","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.bbrc.2015.09.179_bib30","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.2337\/db11-1824","article-title":"Protective effects of GLP-1 on glomerular endothelium and its inhibition by PKCbeta activation in diabetes","volume":"61","author":"Mima","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.bbrc.2015.09.179_bib31","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1152\/physrev.00054.2009","article-title":"Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale","volume":"90","author":"Rose","year":"2010","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbrc.2015.09.179_bib32","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.2337\/db11-1415","article-title":"Impaired MEK signaling and SERCA expression promote ER stress and apoptosis in insulin-resistant macrophages and are reversed by exenatide treatment","volume":"61","author":"Liang","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.bbrc.2015.09.179_bib33","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1161\/CIRCHEARTFAILURE.109.900282","article-title":"Glucagon-like peptide-1 increases myocardial glucose uptake via p38alpha MAP kinase-mediated, nitric oxide-dependent mechanisms in conscious dogs with dilated cardiomyopathy","volume":"3","author":"Bhashyam","year":"2010","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.bbrc.2015.09.179_bib34","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.jhep.2010.09.032","article-title":"Glucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase","volume":"54","author":"Ben-Shlomo","year":"2011","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.bbrc.2015.09.179_bib35","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1007\/s00125-011-2317-z","article-title":"Exenatide decreases hepatic fibroblast growth factor 21 resistance in non-alcoholic fatty liver disease in a mouse model of obesity and in a randomised controlled trial","volume":"54","author":"Samson","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.bbrc.2015.09.179_bib36","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1038\/nm1137","article-title":"Adiponectin-mediated modulation of hypertrophic signals in the heart","volume":"10","author":"Shibata","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2015.09.179_bib37","doi-asserted-by":"crossref","first-page":"E899","DOI":"10.1073\/pnas.1108559108","article-title":"Cardiac myocyte follistatin-like 1 functions to attenuate hypertrophy following pressure overload","volume":"108","author":"Shimano","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2015.09.179_bib38","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/CIRCRESAHA.114.302022","article-title":"Mammalian target of rapamycin signaling in cardiac physiology and disease","volume":"114","author":"Sciarretta","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2015.09.179_bib39","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1146\/annurev.pharmtox.47.120505.105359","article-title":"mTOR pathway as a target in tissue hypertrophy","volume":"47","author":"Lee","year":"2007","journal-title":"Annu. Rev. Pharmacol. Toxicol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X15306781?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X15306781?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T06:18:42Z","timestamp":1567318722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X15306781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":39,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0006291X15306781"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2015.09.179","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exendin-4 attenuates cardiac hypertrophy via AMPK\/mTOR signaling pathway activation","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2015.09.179","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}